• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY 2; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T165
Device Problems Pacing Problem (1439); Device Operates Differently Than Expected (2913)
Patient Problems Heart Failure (2206); Complaint, Ill-Defined (2331)
Event Date 09/23/2012
Event Type  malfunction  
Event Description
Additional information was received indicating that a revision procedure was performed wherein the device was explanted and successfully replaced.Moreover, the left ventricular (lv) port was plugged as the patient¿s left side access was blocked.No additional adverse patient effects were reported.
 
Manufacturer Narrative
(b)(4).The product is expected to be returned for analysis.This report will be updated upon return and completion of analysis.
 
Event Description
Boston scientific received information that during device check for recent patient admission, it was found out that the device reached end of life (eol) a year ago due to charge time issue.Furthermore, this device exhibited pacing inhibition and has now reverted to storage mode; however, a replacement has not been determined at this time.Additional information was received indicating that due to health issues, the physician opted to discharge the patient home with a life vest until such time that the device can safely be replaced with minimal risk of infection.At this time, the device remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
--.
 
Manufacturer Narrative
(b)(4).Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the defibrillation, right ventricular pacing, and sensing functions were tested.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.Laboratory analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY 2
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sharon zurn
4100 hamline ave. n
st. paul, MN 55112
6515824786
MDR Report Key3734364
MDR Text Key4493191
Report Number2124215-2014-06565
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/14/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/14/2007
Device Model NumberT165
Other Device ID NumberVITALITY 2 DR
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/05/2014
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 05/14/2014
Initial Date FDA Received04/08/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received07/09/2014
07/09/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/16/2006
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
T165; 0184; 4469
Patient Age63 YR
-
-